Increasing knowledge of the gut microbiome has revealed that Akkermansia and a bacterial strain that produces butyrate can augment GLP-1 production through natural stimulation of the L-cells. Learn how the gut microbiome and targeted probiotic formulations play a critical role in optimizing the GLP-1 pathway.
Understand the important role of the gut microbiome in the GLP-1 pathway
Recognize which bacterial strains are critical for optimizing GLP-1, including research on Akkermansia and a butyrate-producing bacteria
Acknowledge specific probiotic formulations that show clinical improvements in Type 2 Diabetes
Learn how to address the gut microbiome in clinical practice to support your patients' natural ability to produce GLP-1